Michael R. Costa

Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens

Scott E. Martin, William F. Forrest, Jean-Philippe Fortin, 2019, Genome Biology.

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.

P. Trojer, E. Jackson, D. Arnott, 2016, Nature chemical biology.

ERBB3 and IGF1R signaling are required for Nrf2-dependent growth in KEAP1-mutant lung cancer.

F. Gnad, C. Watanabe, James Lee, 2019, Cancer research.

Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens

Karen E Gascoigne, W. Forrest, P. Haverty, 2018, bioRxiv.

CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing

C. Watanabe, Ben Chih, V. Janakiraman, 2018, Cell Death & Disease.

A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors

J. Fortin, Weiru Wang, Z. Khan, 2022, Proceedings of the National Academy of Sciences of the United States of America.